An investigation of clinical and immunological events following repeated aerodigestive tract challenge infections with live Mycobacterium bovis Bacille Calmette Guérin

Vaccine

Volumn 28, Issue 33, 2010, Pages 5427-5431

  Schreiber, Fernanda ^a   Huo, Zhiming ^b   Giemza, Rafaela ^b   Woodrow, Maria ^b   Fenner, Nicola ^b   Stephens, Zoe ^b   Dougan, Gordon ^a   Prideaux, Steven ^b   Castello Branco, Luiz R R ^c   Lewis, David J M ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

BCG; Innate immunity; Oral challenge

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; LIVE VACCINE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; BLOOD SAMPLING; BOVINE TUBERCULOSIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CYTOKINE RELEASE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL INFECTION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; LOOSE FECES; MALE; MICROARRAY ANALYSIS; MYCOBACTERIUM BOVIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNITY, INNATE; INTESTINAL DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; T-LYMPHOCYTES; TUBERCULOSIS VACCINES;

EID: 77955054130     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.005     Document Type: Article

References (7)

1. Benevolo-de-Andrade T., Monteiro-Maia R., Cosgrove C., Castello-Branco L. BCG Moreau Rio de Janeiro - an oral vaccine against tuberculosis - review. Mem Inst Oswaldo Cruz 2005, 100(5):459-465.
2. Liu J., Tran V., Leung A., Alexander D., Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 2009, 5(2):70-78.
3. Uehori J., Matsumoto M., Tsuji S., Akazawa T., Takeuchi O., Akira S., et al. Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis Bacillus Calmette-Guerin Peptidoglycan. Infect Immun 2003, 71(August (8)):4238-4249.
4. Assis A. Novas perspectivas de Calmettizaçao. Hospital (RioJ) 1950, 37:337-353.
5. Cosgrove C.A., Castello-Branco L.R.R., Hussell T., Sexton A., Giemza R., Phillips R., et al. Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral Vaccine. Infect Immun 2006, 74(April (4)):2449-2452.
6. Miura K., Nagai S., Kinomoto M., Haga S., Tokunaga T. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70. Infect Immun 1983, 39:540-545.
7. Wiker H., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992, 56:648-661.